Marshall Wace LLP purchased a new stake in shares of Lufax Holding Ltd (NYSE:LU - Free Report) in the 4th quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor purchased 2,297,647 shares of the company's stock, valued at approximately $5,491,000. Marshall Wace LLP owned 0.27% of Lufax as of its most recent SEC filing.
Other hedge funds have also recently modified their holdings of the company. Mitsubishi UFJ Trust & Banking Corp bought a new stake in Lufax in the fourth quarter valued at $5,436,000. Norges Bank bought a new stake in shares of Lufax during the 4th quarter valued at about $4,221,000. Charles Schwab Investment Management Inc. increased its position in shares of Lufax by 35.5% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,205,838 shares of the company's stock valued at $10,052,000 after buying an additional 1,102,943 shares during the period. Catalyst Funds Management Pty Ltd raised its stake in Lufax by 999.0% in the fourth quarter. Catalyst Funds Management Pty Ltd now owns 888,000 shares of the company's stock worth $2,122,000 after buying an additional 807,200 shares in the last quarter. Finally, Leading Securities Co Ltd purchased a new stake in Lufax in the fourth quarter worth about $458,000. Hedge funds and other institutional investors own 69.14% of the company's stock.
Lufax Stock Performance
Lufax stock opened at $2.62 on Thursday. Lufax Holding Ltd has a fifty-two week low of $2.00 and a fifty-two week high of $4.94. The stock has a market cap of $2.27 billion, a price-to-earnings ratio of -3.40 and a beta of 0.71. The stock's 50 day simple moving average is $2.86 and its two-hundred day simple moving average is $2.70.
Lufax Company Profile
(
Free Report)
Lufax Holding Ltd operates as a financial service empowering institution for small and micro businesses in China. The company offers loan products, including general unsecured loans and secured loans, as well as consumer finance loans. It also provides wealth management products, such as asset management plans, mutual fund products, private investment fund products, and trust products.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Lufax, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Lufax wasn't on the list.
While Lufax currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
